Delivery Order #75N91025F00016

Leidos Biomedical Multiyear Delivery Order Enhances NCI Cancer Research

This award is a substantial multi-year delivery order contract granted to SAIC-Frederick, Inc., a subsidiary that operates under Leidos Holdings, Inc., known for its expertise in biomedical research and development. The contract supports the National Cancer Institute (NCI) by enhancing critical operational capabilities on NCI's Frederick, Maryland campus, which is vital for advancing cancer research. The contract encompasses management and procurement of specialized laboratory and scientific equipment, maintenance services, and oversight of scientific projects essential to cancer research. This award builds upon a prior indefinite delivery contract associated with the NCI Federally Funded Research and Development Center (FFRDC) program, demonstrating the government's continued commitment to cancer research innovation. The contract was awarded through a competitive bidding process, ensuring transparency and fair procurement practices. Key subcontractors include Vanderbilt University, contributing significant scientific research initiatives; University of North Carolina at Chapel Hill, specializing in validating high-throughput screening assays; and American Type Culture Collection, managing vital central repository locations for research operations. Additional subcontractors, such as PerkinElmer, Bio-Rad Laboratories, Shimadzu Scientific Instruments, and others, provide vital maintenance support and capital equipment essential for laboratory functionality. The scope of work covers infrastructure management, scientific validation, equipment procurement, and ongoing maintenance services that collectively advance cancer research capabilities. The contract’s timeline spans multiple years, affirming a long-term federal dedication to improving public health outcomes through cancer research.

Description

NCI OPERATIONAL TASK ORDER, FY26-FY27

View original record